Medical Billing · Nationwide
Complex surgical urology, office cystoscopy, multi-channel urodynamics, and advanced prostate oncology therapies.
Aethera Healthcare Solutions provides full-service medical billing and revenue cycle management to urology groups and surgery centers across the United States. We handle coding, claims, payment posting, denial management, and A/R follow-up end to end — so your team can stay focused on patient care while your revenue cycle runs cleanly.
Typical urology CPT range we work: 52000, 52601, 55700, 51726–51729.
Cystoscopy bundled into therapeutic procedures (e.g. ureteral stent placement 52332) without appropriate distinct procedural modifiers
Urodynamic study component billing (technical vs professional, pressure flow, electromyography 51784) triggering duplicate claim rejections
Prostate biopsy (55700) and ultrasound guidance (76942) documentation scrutiny by commercial health plans
Part B buy-and-bill oncology injections (Eligard, Lupron, Firmagon) requiring NDC conversion and prompt payment posting
Specialty-trained coders (CPC/CCS) code to the documentation
First-pass claim scrubbing against payer and NCCI edits
Proactive denial prevention and 72-hour denial work
Relentless A/R follow-up to drive days-in-A/R down
Eligibility and prior-auth verification before service
Transparent, real-time reporting in the provider portal
Use these any time — no login required.
How do you handle cystoscopy and stent placement bundling?
We apply NCCI PTP edits and only apply Modifier 59 or XS when the cystoscopy was diagnostic and distinct, protecting your practice from audit clawbacks while maximizing legitimate reimbursement.
Do you bill multi-component urodynamic evaluations?
Yes — we itemize cystometrograms, pressure studies, and sphincter electromyography with accurate modifier 26/TC splits so every aspect of testing is fully paid.
With your permission, we use analytics and advertising services, including business visitor identification. Essential Only keeps these services off. Read our privacy policy.